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Introduction. Smoking tobacco during pregnancy is a prevent-
able risk factor for adverse pregnancy outcomes. The aim of the 
study was to assess the impact of an information and training pro-
gram implemented by the perinatal network of Auvergne, France, 
on smoking during pregnancy. 
Methods. A multi-center before-and-after population-based 
study, based on two cross-sectional surveys, was carried out 
between July 2003 and June 2004, and between December 2008 
and January 2010. Pregnant women aged over 18 years, with a 
fluent command of written and spoken French, were eligible. The 
main outcome was the prevalence of pregnant women who smoked 
daily. The preventive program consisted of informing women and 
healthcare providers and training healthcare providers. Multivar-
iate analysis was performed by means of manual logistic regres-
sion and crude and adjusted Odds Ratios were calculated. 
Findings. “Before” and “after” surveys involved 1027 and 720 
women, respectively. In the “after” survey, a higher percentage of 
women smoked daily at the time of diagnosis (43.49% vs 51.94%, 
adjusted Odds Ratio 1.45 [1.10; 1.90]) and during the third term 
(40.53% vs 51.94%, adjusted Odds Ratio 1.62 [1.24; 2.12]). 
Environmental tobacco smoke exposure among non-smokers was 
higher in the “after” survey: 52.83% vs 69.57% adjusted Odds 
Ratio 1.95 [1.54; 2.47].
Conclusions. The program did not reduce smoking during preg-
nancy. Exposure to environmental tobacco smoke increased. 
French public health authorities should introduce a new policy 
aimed specifically at tackling tobacco use during pregnancy and 
exposure to second-hand smoke, and which takes into account the 
entire environment of pregnant women. 
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Summary
Introduction
It is well documented that maternal smoking during 
pregnancy is a preventable risk factor for adverse preg-
nancy outcomes. Tobacco interferes with the develop-
ment of brain structures, which results in a higher risk 
of low birth weight, stillbirth, pre-term delivery and 
placental detachment  [1-3]. There is also evidence of 
an association between tobacco consumption during 
pregnancy and both infant mortality and the risk of nico-
tine dependence during adolescence [3, 4]. In addition, 
several studies have identified environmental tobacco 
smoke (ETS) as a risk factor for adverse effects on both 
fetuses and children [1-3, 5, 6].
The Prochaska cycle of the process of change has been 
applied to the various stages of tobacco dependence: 
pre-contemplation, contemplation, preparation, action, 
maintenance and relapse. Pregnant women commonly 
go through the Prochaska cycle from the pre-contempla-
tion to the contemplation stages. McBride et al. identi-
fied pregnancy as an appropriate moment to stop smok-
ing [7] and advocated developing preventive procedures 
during this period. 
A national survey conducted in France in 2010 showed 
that tobacco consumption remained a major health prob-
lem and, in particular, that consumption had increased 
among women  [8]. The Association of Users of Com-
puterized Data in Paediatrics, Obstetrics and Gynaecol-
ogy (AUDIPOG) reported in 2008 that, although con-
sumption was lower during pregnancy, 14% of pregnant 
women still smoked. 
Two special interest groups at the university hospital of 
Clermont-Ferrand, Auvergne, France –  the DATAMA-
TER group, a regional hospital research program, and 
the CAFE group, an inter-regional hospital research pro-
gram - and the perinatal network of Auvergne (Réseau 
de Santé Périnatale Auvergne-RSPA) have been working 
on tobacco consumption during pregnancy [9-11]. They 
developed an information and training program target-
ing the general public and healthcare providers, to deal 
with tobacco use in pregnant women.
The main aim of the present study was to assess the im-
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pact of the program on reducing tobacco consumption 
during pregnancy. 
Methods
This study was approved by the ethics committee of 
Clermont-Ferrand (N°2003-AU509 for the “before” sur-
vey and 2007-AU 735 for the “after” survey). 
The perinatal network of Auvergne
Auvergne is a rural region of south-central France with 
an estimated population of 1 343 964 , i.e. 2.1% of the 
French population (http://www.insee.fr/fr/bases-de-
donnees). Auvergne currently has 10  maternity units 
(3 level-I with obstetric units only, 6 level-II with ob-
stetric and neonatology units and 1 level-III with ob-
stetric, neonatology and neonatal hospitalization units). 
Maternity units were reorganized between 2003 and 
2009, and six units were closed. The number of births 
in 2003 and 2004, during the period of the “before” sur-
vey, was 13769 and 13779, respectively, and in 2008 and 
2009, during the period of the “after” survey, 13852 and 
13849, respectively. The rate therefore remained stable 
over time (http://www.insee.fr/fr/themes/detail.asp?reg_
id=99&ref_id=etat-civil-naissances). Created in 1994, 
the RSPA includes all healthcare professionals working 
in the gynecology-obstetric and paediatric units of the 
maternity hospitals of Auvergne, 364 healthcare provid-
ers working in local mother-and-child protection centres 
and in the surgeries of general practitioners (Gps), and 
outpatient gynecologists (https://www.auvergne-perinat.
org/). The RSPA aims to improve pregnant women’s 
health through better coordinated management, the im-
provement of quality of care and the development of 
preventive and educational procedures. To this end, it 
manages computerized medical records throughout the 
regional area and organizes yearly scientific meetings to 
present its research and actions to its members. 
Patients
Women aged 18 years or more, with a fluent command of 
spoken and written French, who lived in the administra-
tive area of Auvergne and had given birth to a baby after 
at least 22 weeks of gestation (or 500 grams in weight) 
were deemed eligible for the study. They were recruited 
at the maternity hospitals at the time of delivery or in the 
immediate post-partum. 
Methods
A multi-center cross-sectional before-and-after popu-
lation-based study was conducted. The “before” survey 
was performed between July 2003 and June 2004 in 
16 maternity hospitals, and the “after” survey between 
December 2008 and January 2010 in 11 such facilities. 
The month in which the survey should be carried out in 
each maternity hospital was randomly selected by the 
statisticians of the university hospital of Auvergne. Data 
were collected over four consecutive weeks. 
Questionnaires were composed of items regarding the 
women’s social characteristics, the course of pregnancy 
and delivery conditions. Women were questioned about 
daily smoking before pregnancy, on diagnosis of preg-
nancy, in the third term and during the immediate post-
partum. Yes/no items investigated ETS at home, at work 
and in the company of family or friends.
The main outcome was the prevalence of pregnant wom-
en who smoked daily. 
All participants gave their informed consent to be en-
rolled. The surveys were approved by a French ethics 
research committee (N°2003-AU 509 for the “before” 
survey and 2007-AU 735 for the “after” survey).
Information and training program
The information and training program was implemented 
by the RSPA, and was addressed both to women and their 
family circles and to healthcare professionals. It was di-
vided into three waves: information of the women and 
family circles, information and training of the healthcare 
providers (Fig. 1). Healthcare providers were midwives, 
obstetricians, gynecologists, pediatricians, psychiatrists 
and general practitioners. 
The first wave consisted of publicizing the results of the 
“before” survey in regional newspapers in September 
2004 and June 2008. The RSPA website created the ses-
sion “addictive behavior” in February 2007 and, in April 
2007, published the national guidelines on addictive 
behavior during pregnancy. The RSPA then produced 
a poster in collaboration with communication advisers 
and smokers. The poster was displayed in the waiting 
rooms of regional maternity hospitals, in local mother-
and-child protection centers, and in the surgeries of gen-
eral practitioners (GPs) and outpatient gynaecologists. 
It was sent to healthcare professionals in January 2008.
The second wave began in June 2005 with one RSPA 
“scientific day” of training devoted to tobacco consump-
tion during pregnancy. In May 2007, the actions imple-
mented by the RSPA to deal with tobacco consumption 
during pregnancy were presented to participants in the 
“scientific day” of the Perinatal Prevention Research In-
formation Association (Association Périnatalité Préven-
tion Recherche Information – APPRI).
The third wave was composed of two sessions (Level 1 
and Level 2) of continuous medical training and educa-
tion (CME). The aims of the Level  1 session were to 
explain tobacco dependence, to train healthcare person-
nel in the management of pregnant women smokers at 
all stages of the Prochaska cycle, and to improve the 
screening of pregnant women. Level  2 sessions aimed 
to strengthen the knowledge of healthcare professionals 
who had already attended session 1, and was based on 
medical histories, role plays, advice on prescribing, and 
an introduction to cognitive behavioral therapies. An in-
strument to measure carbon monoxide levels was given 
to participants after the Level 2 session. All the sessions 
were held over two days, 6 hours a day, by a specialist in 
addictions. Five Level 1 sessions and four Level 2 ses-
sions were held, beginning in December 2007 and Sep-
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Fig. 1. Chronology of the surveys and the information and educational program.
Fig. 2. Flow chart of women involved in the “before and after” study.
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tember 2008, respectively. Fifty-eight healthcare profes-
sionals took part in Level 1 and 14 in Level 2. 
Statistical methods
Descriptive analysis was performed to assess the wom-
en’s characteristics and the prevalence of smoking. As 
the samples from the “before” and “after” surveys were 
non-comparative, a Mantel-Haenszel method was used 
to identify any socio-demographic and medical variables 
that might be confounding factors. A threshold of 10% 
was applied in the Mantel-Haenszel method. Bivariate 
analysis was performed by means of logistic regression 
and calculation of crude Odds ratio (OR) and adjusted 
Odds ratio (aOR) with their 95% Confident Intervals 
(95% CI) for qualitative variables, and by means of Stu-
dent’s t-test for quantitative variables. Multivariate anal-
ysis was then performed by means of manual logistic re-
gression, taking into account all significant interactions. 
Tobacco smoking was compared before pregnancy, at 
the time when pregnancy was diagnosed, during preg-
nancy and in the post-partum period, taking into account 
the confounding factors previously identified. Crude 
Odds ratio (OR) and adjusted Odds ratio (aOR) with 
their 95% CI were calculated on confounding factors. A 
significance threshold of 5% was applied in all the sta-
tistical analyses. Statistical analysis was performed by 
means of SAS software (V9.3. SAS Institute Inc., Carry, 
NC, 2002-2003).
Results
Of the 1132 eligible women in the “before” survey and 
the 840 eligible women in the “after” survey, 1027 and 
720, respectively, were finally included in the present 
study (Fig. 2). 
The descriptive analysis showed no significant differ-
ence in socio-demographic characteristics between the 
“before” and “after” groups; the only exception con-
cerned occupational status, in that a higher percentage 
of women were in employment in the “after” survey: 
73.42% vs 80.06%, OR 1.45 [1.15; 1.83]. Regarding 
the women’s medical data, a significant difference was 
observed only for parity, which was higher in the “be-
fore” survey: 64.97% vs 52.48%, OR 0.60 [0.49; 0.73]. 
Concerning the data on newborns, the only difference 
observed was in the 5-minute Apgar score, with lower 
Apgar scores in the “after” group: 1.37% vs 2.92% OR 
2.17 [1.09; 4.29] (Tab. I). 
Two confounding factors were identified by the Mantel-
Haenszel method: occupational status and parity. In the 
multivariate analysis, occupational status was the sole 
explanatory variable that had an effect. 
The trend in tobacco consumption indicated that a 
higher percentage of women in the “after” survey con-
tinued smoking: 43.49% vs 51.94%, aOR 1.45 [1.10; 
1.90] on diagnosis; 40.53% vs 51.94%, aOR 1.62 [1.24; 
2.12] during the third term, and 39.87% vs 46.46% aOR 
1.31 [1.00; 1.72] in post-partum period. The majority of 
women quit smoking spontaneously before the diagno-
sis rather than after (Tab. II). 
Pregnant women involved in the “after” survey were 
more exposed to at least one kind of ETS: 63.58% vs 
75.24% aOR 1.74 [1.41; 2.15] overall and 52.83% vs. 
69.57% aOR 1.95 [1.54; 2.47] among non-smokers. 
They were also more exposed to ETS at work and in the 
company of family or friends (Tab. III). 
Discussion
Main results
The information and training program failed to reduce 
tobacco consumption during pregnancy. One unexpect-
ed finding was the higher exposure of pregnant women 
to ETS at work and with family or friends. 
Comparisons with other studies
Previous studies have identified distinct trends in to-
bacco consumption during pregnancy, including a sig-
nificant rate of “spontaneous quitters” before pregnancy 
or at the time of diagnosis  [12]. Four studies have as-
sessed the efficacy of training programs on healthcare 
professionals – midwives and the personnel of obstetric 
and pediatric units – and medical students [13-16]. Un-
Tab. I. Descriptive and bivariate analysis of socio-demographic, medical and newborn data among the 1027 and 720 women included in the 







Age of the mothersd [29.73 ± 4.87] (1027) [29.71 ± 5.19] (720) -
Family status (couple) 95.52 (1027) 95.55 (719) 1.01 [0.63; 1.60]
Occupational status (work) 73.42 (1027) 80.06 (697) 1.45 [1.15; 1.83]
Age on first cigaretted [16.44 ± 2.85] (607) [16.18 ± 2.88] (367) -
Parity (≥ 1) 64.97 (1019) 52.48 (707) 0.60 [0.49; 0.73]
Type of pregnancy: single 98.44 (1027) 98.16 (708) 0.85 [0.40; 1.77]
Weeks of gestation at birth [39.17 ± 1.55] (1027) [39.24 ± 1.56] (715) -
≥ 37 weeks 95.81 (984) 94.83 (678) 0.80 [0.51; 1.26]
Birth weighte [3261.74 ± 498.91] (1024) [3243.5 ± 508.4] (717) -
 5-Minute Apgar score < 7 1.37 (1023) 2.92 (720) 2.17 [1.09; 4.29]
am: mean; bsd: Standard Deviation; cN: number of women with information on the variable;  dage in years; e birth weight in grams.
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like the present study, these studies revealed a benefi-
cial effect of the training program. The survey involv-
ing midwives revealed a positive impact on the number 
of cigarettes smoked a day  [13]. The study performed 
in obstetric and pediatric units showed that healthcare 
providers changed their behaviour, though the differ-
ence was not statistically significant for all the outcomes 
measured [14]. Finally, the two studies involving medi-
cal students showed an impact on the students’ confi-
dence and attitude to dealing with tobacco consumption 
during pregnancy [15, 16]. 
Concerning exposure to at least one kind of ETS, the 
self-reported prevalence among non-smokers in the “af-
ter” survey (69.2%) was higher than that recorded by 
Aurrekoetxea in Spain (55.5%) [17]. In the present study, 
ETS exposure at home (23.35%) did not differ from the 
values measured by Aurrekoetxea in Spain (24.7%) and 
the WHO report for EU15 (25%) [17, 18]. By contrast, 
ETS exposure at work (32.15%) was higher than the val-
ues registered by Aurrekoetxea in Spain (9.8%) and the 
WHO report for EU15 (13%) [17, 18]. 
Implications
The rate of spontaneous quitters before pregnancy or on 
diagnosis remained moderate. The advice and support 
of physicians are reported to be effective in encourag-
ing patients to give up smoking [19]. Training healthcare 
professionals is also recognized to have a positive effect 
on smoking cessation, although none of the 15 studies 
included in the recent Cochrane review targeted preg-
nant women  [20]. The consensus is that anti-smoking 
interventions are effective on the both outcomes of both 
mothers and babies and should be implemented in all 
maternity hospitals  [12]. It is important to take advan-
tage of this ‘teachable moment’, to use the term of Mc-
Bride et al. [7], because, if the opportunity is passed up, 
the rate of smoking cessation will be significantly lower 
for several years  [21]. Consequently, prevention pro-
grams such as that organized by the RSPA are of great 
value. However, they could be considerably improved. 
First, such programs should target not only physicians 
but also medical students, through the use of both clas-
sic training methods and web-based training [22]. Sec-
Tab.  II. History of smoking before, during and after pregnancy among the 1027 and 720 women included in the “before” and the “after” 











Before pregnancy 407 (67.05%) (607) 253 (70.28%) (360) 0.81 [0.67; 0.99] 0.83 [0.67; 1.01]
Diagnosis of pregnancy 264 (43.49%) (607) 187 (51.94%) (360) 1.40 [1.08; 1.82] 1.45 [1.10; 1.90]
Third term 246 (40.53%) (607) 187 (51.94%) (360) 1.59 [1.22; 2.06] 1.62 [1.24; 2.12]
Post-partum period 242 (39.87%) (607) 164 (46.46%) (360) 1.31 [1.00; 1.71] 1.31 [1,00; 1.72]
Stop smoking rate Stop smoking rate
Diagnosis of pregnancy 143 (35.14%) (407) 89 (35.18%) (253) 1.00 [0.72; 1.39] 1.00 [0.72; 1.40]
Third term 39 (14.77%) (264) 19 (10.16%) (187) 1.53 [0.85; 2.75] 1.51 [0.84; 2.71]
Post-partum period 5 (2.03%) (246) 27 (14.59%) (185)
Relapse rate Relapse rate
Third term 21 (6.12%) (343) 19 (10.98%) (173) 1.89 [0.99; 3.62] 1.85 [0.95; 3.58]
Post-partum period 1 (0.28%) (361) 4 (2.41%) (166) -
an: number of individuals in that response category; b%: percentage; cN: number of individuals with information on the variable; dCI: Confident Interval; 
eaccording to women’s occupational status. 












At home (yes) 376 (36.61%) (1027) 24 (31.77%) (705) 0.81 [0.66; 0.99] 0.86 [0.70; 1.05]
At work (yes) 237 (31.43%) (754) 197 (37.38%) (527) 1.30 [1.03; 1.65] -
With family or friends (yes) 495 (48.20%) (1027) 461 (66.91%) (689) 2.17 [1.78; 2.65] 2.26 [1.84; 2.78]
At least one type of tobacco exposure 653 (63.58%) (1027) 538 (75.24%) (715) 1.74 [1.41; 2.15] -
Among non-smokers
At home (yes) 168 (22.64%) (742) 117 (23.35%) (501) 1.04 [0.8; 1.36] 1.07 [0.82; 1.41]
At work (yes) 144 (25.31%) (569) 127 (32.15%) (395) 1.40 [1.05; 1.86] -
With family or friends (yes) 275 (37.06%) (742) 282 (57.55%) (490) 2.30 [1.82; 2.91] 2.36 [1.86; 2.99]
At least one type of tobacco exposure 392 (52.83%) (742) 349 (69.57%) (509) 1.95 [1.54; 2.47] -
an: number of individuals in that response category; b%: percentage; cN: number of individuals with information on the variable; dCI: Confident Interval; 
eaccording to women’s occupational status
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ond, they should make healthcare professionals aware 
of pregnant women’s environment (familial and oc-
cupational status, deprivation), psychological health 
and ETS, in order to identify those women’s needs [3, 
23]. Particular attention should also be paid to pregnant 
women’s partners  [3,  24,  25]. Indeed, it is noteworthy 
that, during a woman’s pregnancy, her partner also goes 
through the Prochaska circle. Interventions should there-
fore aim at helping couples to definitively quit smoking. 
Third, preventive programs could also provide specific 
support for women who continue to smoke by including 
face-to-face interventions and group therapy. Incentive 
measures and other strategies, such as physical activ-
ity, also seem to have a positive impact on tobacco con-
sumption [1, 12, 26-29]. Fourth, the program should also 
target the couple at different time-points, such as before 
pregnancy (pre-wedding and family planning consulta-
tions) and in the post-partum period, which is a high-risk 
period for smoking relapse. 
Study limitations
The study has certain limitations. First, “before” and 
“after” surveys should be performed in exactly the same 
conditions. Assessment of the impact of the program may 
have been distorted by the public health measures against 
tobacco consumption introduced by the French govern-
ment. The price of a packet of cigarettes increased by 
about 40% between 2002 and 2004, during the period 
of the “before” study (http://www.inpes.sante.fr/10000/
themes/tabac/consommation/marche-tabac.asp). In addi-
tion, a ban on smoking in public areas was imposed by 
decree in November 2006 and enforced in February 2007 
and January 2008, before the “after” survey. The presence 
of strong legal regulations may explain the increase in ETS 
exposure between the “before” and “after” surveys. This 
increase might have impaired the effects of our prevention 
program. Second, the preventive program was assessed 
by means of a multi-center population-based survey with-
out a control group. Third, no secondary outcomes were 
measured, such as those included in the Cochrane review 
(percentage of follow-up appointments made, percentage 
of self-help materials given, number of “quit dates” pre-
scribed), an omission that prevented us from identifying 
the positive effect of the program [12]. Fourth, the inclu-
sion criterion of a fluent command of spoken and written 
French might have excluded immigrant women, who are 
more exposed to tobacco consumption and ETS [30]. Fi-
nally, the information poster may have given rise to feel-
ings of guilt that were counterproductive. 
Conclusions
In conclusion, the information and training program 
seemed not to have reduced tobacco smoking during 
pregnancy. Moreover, unexpectedly high levels of ETS 
were revealed. Consequently, government authorities 
in France need to introduce new public health policies 
aimed specifically at tackling the problem of tobacco 
use and exposure to ETS during pregnancy. Programs 
that are too broad may leave out parts of the population, 
as shown by the increase in ETS exposure. 
The solution is therefore to build pregnancy-based pro-
grams and to prevent smoking among men and women 
who are going to have children (such as pre-wedding 
intervention). We also need a better understanding of 
the image of tobacco and its dangers and how people 
consider its harmful effects on fetuses. Questions related 
to the environment of pregnant women also need to be 
addressed. Impact measurement and cost-effectiveness 
analyses of every program should be undertaken in order 
to assess how best to implement the strategies. 
Public health stakeholders should be aware that some 
of the programs usually developed may not reach their 
objectives, and that any newly funded program should 
focus more closely on specific targets and provide strong 
evidence of efficacy. 
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